开发具有膜向机制的新型双衍生物,作为强效的阳性抗菌剂

Rongcui Zhong1, Zikai Xu1, Shujun Zhang1

  • 1Affiliated Qingyuan Hospital, Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, State Key Laboratory of Respiratory Disease, and School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, China.

概括

一种新的双衍生物,化合物43,显示出强大的抗菌活性对抗格兰氏阳性细菌. 这种有前途的新型抗生素候选药物有效治疗感染,毒性低,耐药性最小.